CERTARA INC. - COMMON STOCK
13.26
02-May-25 10:29:06
15 minutes delayed
Stocks
-0.03
-0.23%
Today's range
12.79 - 13.47
ISIN
N/A
Source
NASDAQ
-
Certara to Participate in Upcoming Investor Conferences
29 Apr 2025 16:15:00 By Nasdaq GlobeNewswire
-
14 Apr 2025 08:15:00 By Nasdaq GlobeNewswire
-
14 Apr 2025 08:00:00 By Nasdaq GlobeNewswire
-
01 Apr 2025 08:00:00 By Nasdaq GlobeNewswire
-
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
05 Mar 2025 16:15:00 By Nasdaq GlobeNewswire
-
Certara Reports Fourth Quarter 2024 Financial Results
26 Feb 2025 16:15:00 By Nasdaq GlobeNewswire
-
29 Jan 2025 16:15:00 By Nasdaq GlobeNewswire
-
Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results
15 Jan 2025 07:55:00 By Nasdaq GlobeNewswire
-
Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
02 Jan 2025 16:15:00 By Nasdaq GlobeNewswire
-
Certara Showcases 2024 Research Wins With Over 100 Papers Published
02 Dec 2024 16:15:00 By Nasdaq GlobeNewswire
-
Certara Reports Third Quarter 2024 Financial Results
06 Nov 2024 16:15:01 By Nasdaq GlobeNewswire
-
Certara to Participate in the Stephens Annual Investment Conference
28 Oct 2024 16:15:00 By Nasdaq GlobeNewswire
-
Certara Appoints John Reynders as New Independent Board Member
16 Oct 2024 16:15:00 By Nasdaq GlobeNewswire
-
Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024
09 Oct 2024 16:15:00 By Nasdaq GlobeNewswire
-
Certara Completes Acquisition of Chemaxon
02 Oct 2024 16:15:00 By Nasdaq GlobeNewswire
-
Certara’s Simcyp Consortium Celebrates 25th Anniversary
24 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
18 Sep 2024 08:00:00 By Nasdaq GlobeNewswire
-
Certara to Participate in Upcoming Investor Conferences
21 Aug 2024 16:15:00 By Nasdaq GlobeNewswire
-
Certara Launches Phoenix™ Version 8.5 Drug Development Software
15 Aug 2024 16:15:00 By Nasdaq GlobeNewswire
-
Certara Reports Second Quarter 2024 Financial Results
06 Aug 2024 16:15:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >